AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
SIBUTRAMINE - A NOVEL ANTIOBESITY DRUG - A REVIEW OF THE PHARMACOLOGICAL EVIDENCE TO DIFFERENTIATE IT FROM D-AMPHETAMINE AND D-FENFLURAMINE
Authors: HEAL DJ ASPLEY S PROW MR JACKSON HC MARTIN KF CHEETHAM SC
Citation: Dj. Heal et al., SIBUTRAMINE - A NOVEL ANTIOBESITY DRUG - A REVIEW OF THE PHARMACOLOGICAL EVIDENCE TO DIFFERENTIATE IT FROM D-AMPHETAMINE AND D-FENFLURAMINE, International journal of obesity, 22, 1998, pp. 18-28
A COMPARISON OF THE EFFECTS ON CENTRAL 5-HT FUNCTION OF SIBUTRAMINE HYDROCHLORIDE AND OTHER WEIGHT-MODIFYING AGENTS
Authors: HEAL DJ CHEETHAM SC PROW MR MARTIN KF BUCKETT WR
Citation: Dj. Heal et al., A COMPARISON OF THE EFFECTS ON CENTRAL 5-HT FUNCTION OF SIBUTRAMINE HYDROCHLORIDE AND OTHER WEIGHT-MODIFYING AGENTS, British Journal of Pharmacology, 125(2), 1998, pp. 301-308
FUNCTIONAL COUPLING OF HUMAN 5-HT1A RECEPTORS TO HUMAN G-PROTEIN COUPLED INWARD RECTIFIER K+ CHANNELS EXPRESSED IN XENOPUS OOCYTES
Authors: WATT S SUDAN HL CHEETHAM SC MASON R
Citation: S. Watt et al., FUNCTIONAL COUPLING OF HUMAN 5-HT1A RECEPTORS TO HUMAN G-PROTEIN COUPLED INWARD RECTIFIER K+ CHANNELS EXPRESSED IN XENOPUS OOCYTES, British Journal of Pharmacology, 123, 1998, pp. 136-136
BEHAVIORAL-EFFECTS OF THE MONOAMINE REUPTAKE INHIBITOR, BTS-74398, INRATS AND MICE
Authors: JACKSON HC CHEETHAM SC GOSDEN J HUTCHINS LJ KERRIGAN F NEEDHAM AM PLEASANCE IM SARGENT BJ HEAL DJ
Citation: Hc. Jackson et al., BEHAVIORAL-EFFECTS OF THE MONOAMINE REUPTAKE INHIBITOR, BTS-74398, INRATS AND MICE, British Journal of Pharmacology, 123, 1998, pp. 256-256
DOPAMINE UPTAKE SITES, LABELED WITH [H-3]GBR12935, IN BRAIN SAMPLES FROM DEPRESSED SUICIDES AND CONTROLS
Authors: BOWDEN C CHEETHAM SC LOWTHER S KATONA CLE CROMPTON MR HORTON RW
Citation: C. Bowden et al., DOPAMINE UPTAKE SITES, LABELED WITH [H-3]GBR12935, IN BRAIN SAMPLES FROM DEPRESSED SUICIDES AND CONTROLS, European neuropsychopharmacology, 7(4), 1997, pp. 247-252
5-HT1A RECEPTOR-BINDING SITES IN POSTMORTEM BRAIN SAMPLES FROM DEPRESSED SUICIDES AND CONTROLS
Authors: LOWTHER S DEPAERMENTIER F CHEETHAM SC CROMPTON MR KATONA CLE HORTON RW
Citation: S. Lowther et al., 5-HT1A RECEPTOR-BINDING SITES IN POSTMORTEM BRAIN SAMPLES FROM DEPRESSED SUICIDES AND CONTROLS, Journal of affective disorders, 42(2-3), 1997, pp. 199-207
[H-3] PAROXETINE BINDING INDICATES THAT SIBUTRAMINE IS NOT NEUROTOXICAND, LIKE FLUOXETINE, IT PROTECTS AGAINST THE DEFICITS IN 5-HT REUPTAKE SITES PRODUCED BY D-FENFLURAMINE
Authors: CHEETHAM SC VIGGERS JA SLATER NA HEAL DJ
Citation: Sc. Cheetham et al., [H-3] PAROXETINE BINDING INDICATES THAT SIBUTRAMINE IS NOT NEUROTOXICAND, LIKE FLUOXETINE, IT PROTECTS AGAINST THE DEFICITS IN 5-HT REUPTAKE SITES PRODUCED BY D-FENFLURAMINE, British Journal of Pharmacology, 120, 1997, pp. 349-349
CHRONIC ADMINISTRATION OF SIBUTRAMINE REDUCES PLASMA-GLUCOSE LEVELS IN OBESE HYPERGLYCEMIC (OB OB) MICE/
Authors: JONES RB JACKSON HC CHEETHAM SC ANTHONY DM SILLS S HEAL DJ BUCKETT WR
Citation: Rb. Jones et al., CHRONIC ADMINISTRATION OF SIBUTRAMINE REDUCES PLASMA-GLUCOSE LEVELS IN OBESE HYPERGLYCEMIC (OB OB) MICE/, British Journal of Pharmacology, 120, 1997, pp. 352-352
REDUCED DOPAMINE TURNOVER IN THE BASAL GANGLIA OF DEPRESSED SUICIDES
Authors: BOWDEN C CHEETHAM SC LOWTHER S KATONA CLE CROMPTON MR HORTON RW
Citation: C. Bowden et al., REDUCED DOPAMINE TURNOVER IN THE BASAL GANGLIA OF DEPRESSED SUICIDES, Brain research, 769(1), 1997, pp. 135-140
DOPAMINE D-1 AND D-2 RECEPTOR-BINDING SITES IN BRAIN SAMPLES FROM DEPRESSED SUICIDES AND CONTROLS
Authors: BOWDEN C THEODOROU AE CHEETHAM SC LOWTHER S KATONA CLE CROMPTON MR HORTON RW
Citation: C. Bowden et al., DOPAMINE D-1 AND D-2 RECEPTOR-BINDING SITES IN BRAIN SAMPLES FROM DEPRESSED SUICIDES AND CONTROLS, Brain research, 752(1-2), 1997, pp. 227-233
BINDING OF ZOTEPINE TO SEROTONIN (5-HT) RECEPTOR SUBTYPES
Authors: NEEDHAM PL ATKINSON J CHEETHAM SC DINNIS D SLATER NA OBRIEN E HEAL DJ
Citation: Pl. Needham et al., BINDING OF ZOTEPINE TO SEROTONIN (5-HT) RECEPTOR SUBTYPES, Schizophrenia research, 18(2-3), 1996, pp. 9-9
[H-3] NISOXETINE - A RADIOLIGAND FOR NORADRENALINE REUPTAKE SITES - CORRELATION WITH INHIBITION OF [H-3] NORADRENALINE UPTAKE AND EFFECT OFDSP-4 LESIONING AND ANTIDEPRESSANT TREATMENTS
Authors: CHEETHAM SC VIGGERS JA BUTLER SA PROW MR HEAL DJ
Citation: Sc. Cheetham et al., [H-3] NISOXETINE - A RADIOLIGAND FOR NORADRENALINE REUPTAKE SITES - CORRELATION WITH INHIBITION OF [H-3] NORADRENALINE UPTAKE AND EFFECT OFDSP-4 LESIONING AND ANTIDEPRESSANT TREATMENTS, Neuropharmacology, 35(1), 1996, pp. 63-70
EFFECT OF THE SELECTIVE 5-HT1B 1D RECEPTOR ANTAGONIST, GR127935, IN COMBINATION WITH FLUOXETINE ON RAT-BRAIN 5-HYROXYTRYPTOPHAN LEVELS/
Authors: SPENCER EL BUTLER SA SLATER NA ASPLEY S CHEETHAM SC MARTIN KF HEAL DJ
Citation: El. Spencer et al., EFFECT OF THE SELECTIVE 5-HT1B 1D RECEPTOR ANTAGONIST, GR127935, IN COMBINATION WITH FLUOXETINE ON RAT-BRAIN 5-HYROXYTRYPTOPHAN LEVELS/, British Journal of Pharmacology, 119, 1996, pp. 183-183
EFFECT OF ANTIDEPRESSANT DRUGS ON 5-HT2A RECEPTORS IN CULTURED RAT GLIOMA C-6 CELLS
Authors: VIGGERS JA CHEETHAM SC RUCK A HEAL DJ
Citation: Ja. Viggers et al., EFFECT OF ANTIDEPRESSANT DRUGS ON 5-HT2A RECEPTORS IN CULTURED RAT GLIOMA C-6 CELLS, British Journal of Pharmacology, 117, 1996, pp. 134-134
BINDING OF ZOTEPINE, CLOZAPINE AND HALOPERIDOL TO 5-HT RECEPTOR SUBTYPES
Authors: NEEDHAM PL ATKINSON J CHEETHAM SC DINNIS D SLATER NA OBRIEN EC HEAL DJ
Citation: Pl. Needham et al., BINDING OF ZOTEPINE, CLOZAPINE AND HALOPERIDOL TO 5-HT RECEPTOR SUBTYPES, British Journal of Pharmacology, 117, 1996, pp. 140-140
EVIDENCE THAT DIZOCILPINE (MK-801) DOES NOT DOWN-REGULATE EITHER BETA(1)-ADRENOCEPTORS OR 5-HT2A RECEPTORS IN RAT-BRAIN
Authors: LOVE RM HUTCHINS LJ JACKSON HC HEAL DJ CHEETHAM SC
Citation: Rm. Love et al., EVIDENCE THAT DIZOCILPINE (MK-801) DOES NOT DOWN-REGULATE EITHER BETA(1)-ADRENOCEPTORS OR 5-HT2A RECEPTORS IN RAT-BRAIN, British Journal of Pharmacology, 117, 1996, pp. 329-329
D-1 RECEPTOR-BINDING IN RAT STRIATUM - MODIFICATION BY VARIOUS D-1 AND D-2 ANTAGONISTS, BUT NOT BY SIBUTRAMINE HYDROCHLORIDE, ANTIDEPRESSANTS OR TREATMENTS WHICH ENHANCE CENTRAL DOPAMINERGIC FUNCTION
Authors: CHEETHAM SC KETTLE CJ MARTIN KF HEAL DJ
Citation: Sc. Cheetham et al., D-1 RECEPTOR-BINDING IN RAT STRIATUM - MODIFICATION BY VARIOUS D-1 AND D-2 ANTAGONISTS, BUT NOT BY SIBUTRAMINE HYDROCHLORIDE, ANTIDEPRESSANTS OR TREATMENTS WHICH ENHANCE CENTRAL DOPAMINERGIC FUNCTION, Journal of neural transmission, 102(1), 1995, pp. 35-46
DOPAMINE D-2 RECEPTORS - A POTENTIAL PHARMACOLOGICAL TARGET FOR NOMIFENSINE AND TRANYLCYPROMINE BUT NOT OTHER ANTIDEPRESSANT TREATMENTS
Authors: MARTIN KF PHILLIPS I CHEETHAM SC HEAL DJ
Citation: Kf. Martin et al., DOPAMINE D-2 RECEPTORS - A POTENTIAL PHARMACOLOGICAL TARGET FOR NOMIFENSINE AND TRANYLCYPROMINE BUT NOT OTHER ANTIDEPRESSANT TREATMENTS, Pharmacology, biochemistry and behavior, 51(4), 1995, pp. 565-569
RECEPTOR-BINDING AND FUNCTIONAL EVIDENCE SUGGEST THAT POSTSYNAPTIC ALPHA(2)-ADRENOCEPTORS IN RAT-BRAIN ARE OF THE ALPHA(2D) SUBTYPE
Authors: HEAL DJ CHEETHAM SC BUTLER SA GOSDEN J PROW MR BUCKETT WR
Citation: Dj. Heal et al., RECEPTOR-BINDING AND FUNCTIONAL EVIDENCE SUGGEST THAT POSTSYNAPTIC ALPHA(2)-ADRENOCEPTORS IN RAT-BRAIN ARE OF THE ALPHA(2D) SUBTYPE, European journal of pharmacology, 277(2-3), 1995, pp. 215-221
EVALUATION OF GLYCINE NMDA RECEPTOR ANTAGONISTS IN AN ANIMAL-MODEL OFDEPRESSION/
Authors: LOVE R JACKSON HC HUTCHINS LJ CHEETHAM SC HEAL DJ
Citation: R. Love et al., EVALUATION OF GLYCINE NMDA RECEPTOR ANTAGONISTS IN AN ANIMAL-MODEL OFDEPRESSION/, British Journal of Pharmacology, 116, 1995, pp. 119-119
[H-3] SUMATRIPTAN IS A NOVEL RADIOLIGAND FOR LABELING 5-HT1D SITES - BINDING IN PIG CAUDATE MEMBRANES
Authors: CHEETHAM SC SLATER NA VIGGERS JA OBRIEN EC HEAL DJ
Citation: Sc. Cheetham et al., [H-3] SUMATRIPTAN IS A NOVEL RADIOLIGAND FOR LABELING 5-HT1D SITES - BINDING IN PIG CAUDATE MEMBRANES, British Journal of Pharmacology, 114, 1995, pp. 363-363
ADMINISTRATION OF EEDQ ATTENUATES 5-HT2A RECEPTOR-STIMULATED, BUT NOTG-PROTEIN-STIMULATED PHOSPHOINOSITIDE HYDROLYSIS IN RAT FRONTAL-CORTEX
Authors: KETTLE CJ MARTIN KF CHEETHAM SC HEAL DJ
Citation: Cj. Kettle et al., ADMINISTRATION OF EEDQ ATTENUATES 5-HT2A RECEPTOR-STIMULATED, BUT NOTG-PROTEIN-STIMULATED PHOSPHOINOSITIDE HYDROLYSIS IN RAT FRONTAL-CORTEX, British Journal of Pharmacology, 114, 1995, pp. 367-367
THE ANXIOLYTIC EFFECTS OF SELECTIVE 5-HT REUPTAKE INHIBITORS IN THE ELEVATED PLUS-MAZE ARE NOT EXPLAINED BY REUPTAKE INHIBITION OR AFFINITYFOR 5-HT1A,2A,2C AND 3 RECEPTOR SUBTYPES
Authors: JACKSON HC CHEETHAM SC LUSCOMBE GP MAZURKIEWICZ SE VIGGERS JA HEAL DJ
Citation: Hc. Jackson et al., THE ANXIOLYTIC EFFECTS OF SELECTIVE 5-HT REUPTAKE INHIBITORS IN THE ELEVATED PLUS-MAZE ARE NOT EXPLAINED BY REUPTAKE INHIBITION OR AFFINITYFOR 5-HT1A,2A,2C AND 3 RECEPTOR SUBTYPES, British Journal of Pharmacology, 114, 1995, pp. 391-391
EVIDENCE THAT OPIOIDS ARE NOT INVOLVED IN THE DOWN-REGULATION OF CENTRAL BETA-1-ADRENOCEPTORS AND ALPHA-2-ADRENOCEPTORS BY SIMULATED ELECTROCONVULSIVE-THERAPY
Authors: OGILVIE J CHEETHAM SC GOSDEN J BUTLER SA HEAL DJ
Citation: J. Ogilvie et al., EVIDENCE THAT OPIOIDS ARE NOT INVOLVED IN THE DOWN-REGULATION OF CENTRAL BETA-1-ADRENOCEPTORS AND ALPHA-2-ADRENOCEPTORS BY SIMULATED ELECTROCONVULSIVE-THERAPY, British Journal of Pharmacology, 114, 1995, pp. 409-409
[H-3] NISOXETINE, A NOVEL LIGAND FOR NORADRENALINE (NA) UPTAKE SITES - CORRELATIONS WITH INHIBITION OF [H-3] NA UPTAKE AND LOSS OF NA NERVE-TERMINALS AFTER DENERVATION
Authors: CHEETHAM SC VIGGERS JA BUTLER SA PROW MR HEAL DJ
Citation: Sc. Cheetham et al., [H-3] NISOXETINE, A NOVEL LIGAND FOR NORADRENALINE (NA) UPTAKE SITES - CORRELATIONS WITH INHIBITION OF [H-3] NA UPTAKE AND LOSS OF NA NERVE-TERMINALS AFTER DENERVATION, British Journal of Pharmacology, 112, 1994, pp. 210000080-210000080
Risultati: 1-25 | 26-31